Print This Page Email This Page Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceutical ingredients Bayer CropScience Plant Explosion Kills One Hexion Rejects Huntsman Shareholder Plan to Salvage BuyoutMonsanto, Evogene Team Up for Stress-Resistant GenesPetroChina Posts Big Increases in Chemical Profits and SalesSiegfried Posts Higher Earnings and Revenues Related Stories Rhodia Returns to Profit …Rhodia to Close Fine Chemicals Plant in FranceNeste, Total Scrap Biodiesel JVToyo Ink Invests and Cuts Jobs at French Sites Rhodia Makes Bond Offering

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

March 14, 2007

… Restructures, and Evaluates Fine Chemicals

Chemical Week Editorial Staff

Clamadieu: Suppliers under pressure. Rhodia CEO Jean-Pierre Clamadieu says the company is restructuring its fine organics business, which supplies chemical intermediates to the pharmaceutical industry. Rhodia will decide whether it will keep the business or sell it...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers